D-0850-2026 Class I Ongoing
FDA drug recall D-0850-2026 was initiated by Baxter Healthcare Corporation on August 17, 2026 and is designated Class I. Reason for recall: Presence of Particulate Matter: particulate matter identified as stainless steel particles in the solution. The recall status is ongoing. Affected quantity: 606 bags.
Recall Details
- Product Type
- Drugs
- Report Date
- September 16, 2026
- Initiation Date
- August 17, 2026
- Termination Date
- N/A
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 606 bags
Product Description
Dextrose Injection, USP, 70 %, 2000 mL bags, Rx Only, Baxter Healthcare Corporation Deerfield, IL, 60016, Made in USA, NDC 00338-0719-06
Reason for Recall
Presence of Particulate Matter: particulate matter identified as stainless steel particles in the solution.
Distribution Pattern
U.S. Nationwide.
Code Information
Lot #: Y495066, Exp. Date July 31, 2027